Semaglutide Prescription GLP-1 weight-loss medication GLP-1 receptor agonist Taken weekly Tirzepatide Prescription medication that targets two appetite-regulating hormones Dual receptor agonist (inhibits GIP and GLP-1 receptors) Taken weekly *In clinical trials studying Wegovy (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone)
Peptide medications may make you feel fuller to help with weight loss
Drinking alcohol with high-fat meals can interfere with GLP-1 secretion and affect blood sugar levels
Factors that likely influence individual response include baseline heart rate, cardiovascular fitness level, autonomic nervous system tone, body composition, and potentially genetic variations in glucagon receptor density or sensitivity
Operational Label Literacy: How to Read a COA and Dose Correctly Reading a peptide COA A credible COA for a research peptide must contain all three of the following
Starting and Maintenance Dose of Ozempic The semaglutide maintenance dose is typically administered once a week, but in some cases, a healthcare provider may recommend a less frequent dosing schedule, such as every other week